Analysts' Top Materials Picks: Orica Limited (OCLDF), James Hardie (JHIUF)

There's a lot to be optimistic about in the Materials sector as 3 analysts just weighed in on Orica Limited (OCLDF – Research Report), James Hardie (JHIUF – Research Report) and Titan Minerals Ltd (TTTNF – Research Report) with bullish sentiments.
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Orica Limited (OCLDF)
In a report issued on May 9, Jakob Cakarnis from Jarden maintained a Buy rating on Orica Limited, with a price target of A$19.70. The company's shares closed last Wednesday at $9.60.
According to TipRanks.com, Cakarnis is a 4-star analyst with an average return of 9.9% and a 66.1% success rate. Cakarnis covers the Industrial Goods sector, focusing on stocks such as Cleanaway Waste Management, Emeco Holdings Limited, and Qantas Airways Limited.
Currently, the analyst consensus on Orica Limited is a Strong Buy with an average price target of $13.63, which is a 42.0% upside from current levels. In a report issued on May 7, Citi also upgraded the stock to Buy with a A$18.90 price target.
James Hardie (JHIUF)
Jarden analyst Rohan Gallagher maintained a Buy rating on James Hardie on May 8 and set a price target of A$44.00. The company's shares closed last Friday at $22.01.
According to TipRanks.com, Gallagher is a 4-star analyst with an average return of 7.5% and a 56.7% success rate. Gallagher covers the Basic Materials sector, focusing on stocks such as Bluescope Steel, Brickworks Ltd, and Sims.
James Hardie has an analyst consensus of Moderate Buy, with a price target consensus of $32.93, which is a 49.6% upside from current levels. In a report issued on May 7, Morgan Stanley also maintained a Buy rating on the stock with a A$55.00 price target.
Titan Minerals Ltd (TTTNF)
In a report issued on May 8, Paul Howard CFA from Canaccord Genuity maintained a Buy rating on Titan Minerals Ltd, with a price target of A$1.18. The company's shares closed last Tuesday at $0.96.
According to TipRanks.com, CFA is a 1-star analyst with an average return of -3.1% and a 47.4% success rate. CFA covers the Basic Materials sector, focusing on stocks such as Adriatic Metals Shs Chess Deposit Interests Repr 1 Sh, West African Resources Ltd, and Emerald Resources NL.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Insider

3 hours ago

• Business Insider

Dassault Systemes price target lowered to EUR 27 from EUR 28 at Jefferies

Jefferies lowered the firm's price target on Dassault Systemes (DASTY) to EUR 27 from EUR 28 and keeps an Underperform rating on the shares. The firm says ongoing macro uncertainty means positive surprises are unlikely in the company's Q2. It believes questions over whether Dassault will meet guidance are persist until year-end. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Business Insider

4 hours ago

• Business Insider

Sarepta price target lowered to $30 from $84 at JPMorgan

JPMorgan lowered the firm's price target on Sarepta (SRPT) to $30 from $84 and keeps an Overweight rating on the shares. The firm made changes to its revenue assumptions for key Elevidys post the disclosure of second non-ambulatory patient death. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Business Insider

4 hours ago

• Business Insider

Sage Therapeutics price target lowered to $8.50 from $11 at JPMorgan

JPMorgan analyst Anupam Rama lowered the firm's price target on Sage Therapeutics (SAGE) to $8.50 from $11 and keeps a Neutral rating on the shares. The firm cites the acquisition deal price by Supernus Pharmaceuticals for the target cut. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>